Skip to main content
. 2023 Feb 7;14:1127201. doi: 10.3389/fphar.2023.1127201

TABLE 1.

Inclusion/exclusion criteria for shortlisting of the compounds.

Name Criteria
1 Lipinski and other violations Zero violations
2 Molecular weight (MW) 150–500
3 TPSA 20–130
4 GI absorption High
5 BBB permeability No
6 Medicinal chemistry violations Zero violations
7 Water solubility Soluble/very soluble
8 Cardiotoxicity (hERG prediction) No
9 CYP450 inhibition Non-inhibitor